文献速递胸部CT

ITHscore:基于多尺度影像组学特征的综合量化非小细胞肺癌瘤内异质性

ITHscore: comprehensive quantification of intra-tumor heterogeneity in NSCLC by multi-scale radiomic features.
PubMed 文献 · Eur Radiol · 2022-08-24

本研究开发了量化非小细胞肺癌(NSCLC)瘤内异质性(ITH)的影像组学指标ITHscore,整合局部影像组学特征与全局像素分布模式,在六个队列(n=1399)中验证其与肿瘤表型、基因型和预后的关联。结果显示ITHscore与I期NSCLC进展、病理恶性程度、淋巴血管侵犯和胸膜侵犯相关,并能区分不同总生存和无病生存的患者组,放射基因组分析提示其与异质性相关通路相关,且可推广至头颈癌。

要点

  • ITHscore可用于NSCLC的瘤内异质性量化,与肿瘤表型、基因型和预后相关。
  • 在I期NSCLC中,ITHscore与肿瘤进展(IA1至IA3)和病理恶性程度相关。
  • ITHscore可区分淋巴血管侵犯和胸膜侵犯,并区分不同生存状态的患者组。

核心结论

  • NSCLC的瘤内异质性可通过CT图像计算的ITHscore进行量化,该指标与肿瘤表型和患者预后相关。
  • ITHscore在I期和II期NSCLC中与异质性相关通路相关,并可能推广至其他癌症类型如头颈癌。

研究设计与样本

  • 研究为影像组学指标开发与多队列验证研究,共纳入六个患者队列(n=1399),基于CT图像计算ITHscore。
  • 参考标准包括肿瘤分期、病理特征、基因型和患者生存预后。

诊断标准与关键数值

  • ITHscore与I期NSCLC从IA1到IA3的肿瘤进展一致(p < 0.001),并捕捉恶性程度的關鍵病理变化(p < 0.001)。
  • ITHscore可区分淋巴血管侵犯(p = 0.003)和胸膜侵犯(p = 0.001)。
  • ITHscore可区分不同总生存(p = 0.004)和无病生存(p = 0.005)的患者组。

临床应用与阅片要点

  • ITHscore可作为CT影像组学生物标志物,辅助评估NSCLC瘤内异质性、肿瘤侵袭性和患者预后。
  • 在I期NSCLC中,ITHscore有助于提示病理恶性程度、淋巴血管侵犯和胸膜侵犯风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To quantify intra-tumor heterogeneity (ITH) in non-small cell lung cancer (NSCLC) from computed tomography (CT) images.

METHODS: We developed a quantitative ITH measurement-ITHscore-by integrating local radiomic features and global pixel distribution patterns. The associations of ITHscore with tumor phenotypes, genotypes, and patient's prognosis were examined on six patient cohorts (n = 1399) to validate its effectiveness in characterizing ITH.

RESULTS: For stage I NSCLC, ITHscore was consistent with tumor progression from stage IA1 to IA3 (p < 0.001) and captured key pathological change in terms of malignancy (p < 0.001). ITHscore distinguished the presence of lymphovascular invasion (p = 0.003) and pleural invasion (p = 0.001) in tumors. ITHscore also separated patient groups with different overall survival (p = 0.004) and disease-free survival conditions (p = 0.005). Radiogenomic analysis showed that the level of ITHscore in stage I and stage II NSCLC is correlated with heterogeneity-related pathways. In addition, ITHscore was proved to be a stable measurement and can be applied to ITH quantification in head-and-neck cancer (HNC).

CONCLUSIONS: ITH in NSCLC can be quantified from CT images by ITHscore, which is an indicator for tumor phenotypes and patient's prognosis.

KEY POINTS: • ITHscore provides a radiomic quantification of intra-tumor heterogeneity in NSCLC. • ITHscore is an indicator for tumor phenotypes and patient's prognosis. • ITHscore has the potential to be generalized to other cancer types such as HNC.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Li, Qiu, Zhang, et al. ITHscore: comprehensive quantification of intra-tumor heterogeneity in NSCLC by multi-scale radiomic features. Eur Radiol. 2022. PMID: 36001124. doi:10.1007/s00330-022-09055-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。